Apart from expected significant differences in baseline and current CD4 T-cell counts as well as CD4:CD8 ratio between the oIR and sIR groups, all other HIV-related clinical variables and hepatitis B/C co-infection status were comparable in the two groups. This evidence concerns the gene CD8A and hepatitis B virus infection.